Explore the detriments associated with two of the most common diabetes comorbidities.
Read More »A Link Between ESRD and Low BMI
Study of BMI and ESRD suggests obesity may provide a health benefit when it comes to end-stage renal disease.
Read More »Renal Disease Impact On Long-Term Metformin Use
As we are all familiar with how metformin can impact patients with existing renal disease, researchers aimed to study how far the limitations can be pushed.
Read More »Prediabetes and Risk for CKD
People with prediabetes and diabetes are at a higher risk of developing chronic kidney disease (CKD) as well as chronic cardiovascular diseases.
Read More »Diabetes May Be a Risk Factor in All-Cause Mortality
Individuals with a high glucose variability are at risk of developing high-mortality conditions such as arteriosclerosis and sustained hyperglycemic episodes.
Read More »Diabetic Kidney Disease Prevention
A new study in Japan researched the association between HbA1c levels and body mass index, and its effect on the kidney.
Read More »Risk Factors for Advanced Kidney Disease in Patients with Type 1 Diabetes
How to identify who is at risk for the progression of diabetic kidney disease to end-stage renal disease?
Read More »Can Metformin be Used With Impaired Kidney Function?
Results from a retrospective cohort comparing metformin vs. sulfonylurea use in reduced kidney function.
Read More »Cardiovascular and Renal Benefits of SGLT2 Inhibitors
The use of SGLT-2 inhibitors produces cardiovascular benefits and reduces the risk of progression of renal impairment in patients with T2DM.
Read More »Canagliflozin’s Efficacy and Safety For Delaying and Possibly Preventing ESKD
Kidney failure is an enormous concern for people with T2D and DKD. This analysis confirms canagliflozin can slow its progression and have an impact on patients regardless of their level of kidney function.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.